Physician profile
Yvette M Smith
NPI 1093812943
$1,839.59
in general payments reported to CMS, 2019-2025
31 companies · $285 in 2025
The $285 reported for 2025 was more than what a typical Obstetrics & Gynecology provider received nationally (typical 2025 total: $158).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $518 · 2020: $85.32 · 2021: $198 · 2022: $107 · 2023: $500 · 2024: $146 · 2025: $285.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $812 · Education: $119.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $811.83 |
| Education | $119.26 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $505.81 | 2019-2023 | Lo Loestrin Fe |
| Astellas Pharma US INC | $175.63 | 2023-2025 | Veozah, Myrbetriq |
| Gynesonics, INC. | $161.82 | 2023 | Sonata Sonography-Guided Transcervical Fibroid Ablation System |
| Optumhealth Care Solutions, LLC | $83.51 | 2025 | Eitan Medical, Vivify Health Care Team Portal 001 |
| Therapeuticsmd, INC. | $80.23 | 2019-2021 | |
| Organon LLC | $78.67 | 2021-2025 | Nexplanon, Jada System |
| Mayne Pharma Commercial LLC | $57.17 | 2023-2025 | |
| Agile Therapeutics, INC. | $54.48 | 2021-2022 | |
| Hologic Sales and Service, LLC | $52.59 | 2019-2025 | Aptima |
| Merck Sharp & Dohme LLC | $51.54 | 2019-2025 | Gardasil 9, Gardasil |
| Coopersurgical, INC. | $50.16 | 2024-2025 | Paragard T 380a |
| Millicent US INC | $42.69 | 2024-2025 | Femlyv, Intrarosa |
| Pfizer INC. | $41.72 | 2023 | |
| Myovant Sciences INC. | $36.11 | 2021 | |
| Duchesnay USA Incorporated | $35.78 | 2019 |
Show all 31 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Medtronic, INC. | $34.96 | 2024 | Interstim |
| Vertex Pharmaceuticals Incorporated | $32.17 | 2025 | |
| Vertical Pharmaceuticals, LLC | $27.03 | 2019 | |
| Allergan, INC. | $24.84 | 2019 | |
| Bayer Healthcare Pharmaceuticals INC. | $23.91 | 2019-2020 | |
| Mycovia Pharmaceuticals, INC. | $23.67 | 2023 | Vivjoa |
| Solventum Corporation | $21.60 | 2025 | Prevena |
| Medtronic USA, INC. | $21.12 | 2019 | |
| Sumitomo Pharma America, INC. | $19.04 | 2025 | Myfembree |
| Scynexis, INC. | $18.65 | 2022 | |
| Lupin INC. | $16.46 | 2020 | |
| Daiichi Sankyo INC. | $16.07 | 2021 | |
| Mylan Pharmaceuticals INC. | $13.53 | 2019 | |
| Amag Pharmaceuticals, INC. | $13.51 | 2019 | |
| Gilead Sciences, INC. | $13.21 | 2019 | |
| Avion Pharmaceuticals | $11.91 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Yvette Smith listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.